首页> 美国卫生研究院文献>other >Identification of 5-Nitrofuran-2-Amide Derivatives that Induce Apoptosis in Triple Negative Breast Cancer Cells by Activating C/EBP-Homologous Protein Expression
【2h】

Identification of 5-Nitrofuran-2-Amide Derivatives that Induce Apoptosis in Triple Negative Breast Cancer Cells by Activating C/EBP-Homologous Protein Expression

机译:通过激活C / EBP同源蛋白表达鉴定可诱导三阴性乳腺癌细胞凋亡的5-硝基呋喃-2-酰胺衍生物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The transcription factor C/EBP-homologous protein (CHOP) is a key component of the terminal unfolded protein response (UPR) that mediates unresolvable endoplasmic reticulum stress-induced apoptosis. CHOP induction is known to cause cancer cell death. Chemicals that induce CHOP expression would thus be valuable as potential cancer therapeutics and as research tools. Here, we identified 5-nitrofuran-2-amide derivatives as small molecule activators of CHOP expression that induced apoptosis in triple negative breast cancer (TNBC) cells. Our preliminary structure-activity relationship studies indicated that compounds with an N-phenyl-5-nitrofuran-2-carboxamide skeleton were particularly potent inducers of TNBC cell apoptosis. The compounds activate CHOP expression via the PERK–eIF2α–ATF4 branch of the UPR. These results indicate that small molecule activators of CHOP expression may have therapeutic potential for TNBC.
机译:转录因子C / EBP同源蛋白(CHOP)是终末折叠蛋白反应(UPR)的关键成分,该蛋白介导无法解决的内质网应激诱导的细胞凋亡。已知CHOP诱导会导致癌细胞死亡。因此,诱导CHOP表达的化学物质作为潜在的癌症治疗剂和研究工具将是有价值的。在这里,我们确定5-硝基呋喃-2-酰胺衍生物作为CHOP表达的小分子激活剂,可诱导三阴性乳腺癌(TNBC)细胞凋亡。我们初步的构效关系研究表明,具有N-苯基-5-硝基呋喃-2-羧酰胺骨架的化合物特别有效地诱导TNBC细胞凋亡。这些化合物通过UPR的PERK–eIF2α–ATF4分支激活CHOP表达。这些结果表明CHOP表达的小分子激活剂可能对TNBC具有治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号